Long-Term Assets: The sum of all assets classified as non-current.
Prima BioMed Ltd (IMMP) had Long-Term Assets of $4.87M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$91.78M |
|
$0.09M |
|
|
Long-Term Assets |
$4.87M |
$96.65M |
|
$30.87M |
|
-- |
|
$0.85M |
|
$31.72M |
|
$64.94M |
|
$61.03M |
|
$64.94M |
|
147.37M |
|
| Cash Flow Statement Financials | |
$-18.81M |
|
$23.19M |
|
$-0.07M |
|
$44.26M |
|
$47.77M |
|
$3.51M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|